paris

Ipsen announces changes to its Executive Committee

PARIS, FRANCE, 23 July 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care biopharmaceutical company, today announced the…

3 days ago

A year on, Paris 2024 belongs to everyone

22 July 2025 - A year ago, beneath a stormy summer sky, history unfolded along the River Seine. For the first…

3 days ago

EssilorLuxottica to acquire PUcores division dedicated to the development, manufacturing and sale of ophthalmic lens materials

EssilorLuxottica to acquire PUcore’s division dedicated to the development, manufacturing and sale of ophthalmic lens materials  The acquisition will enhance…

4 days ago

Xinhua Silk Road: Ancient ethnic Chinese legacy revealing cultural fusion inscribed as UNESCO World Heritage

BEIJING, July 17, 2025 /PRNewswire/ -- The Xixia Imperial Tombs were inscribed on the World Heritage List on July 11 during…

1 week ago

Chteau Galoupet unveils an exceptional brand home and launches its latest cuve

PARIS, July 17, 2025 /PRNewswire/ -- In July 2025, Château Galoupet, a historic Cru Classé within the prestigious Côtes-de-Provence designation and…

1 week ago

IOC documentary series starring Simone Biles nominated for Primetime Emmy Award

16 July 2025 - The acclaimed Netflix documentary series following seven-time Olympic champion Simone Biles on her remarkable journey to the…

1 week ago

The Seine Reopens: How the Olympic Games Helped Paris Reclaim Its River

10 July 2025 - For the first time in over a century, Parisians are once again swimming in the River Seine.…

2 weeks ago

Countries Urged to Establish National Refrigeration Committees to Tackle Food, Health, Animals and Climate Challenges

PARIS, June 26, 2025 /PRNewswire/ -- On the occasion of World Refrigeration Day, the International Institute of Refrigeration (IIR) is calling…

3 weeks ago

Monthly information on share capital and company voting rights

PARIS, July 04, 2025 (GLOBE NEWSWIRE) -- (Article 223-16 of General Regulation of the French financial markets authority) Listing market:…

3 weeks ago

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer

PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN…

3 weeks ago